Back
Protagonist Therapeutics Quote, Financials, Valuation and Earnings
Buy
75
PTGX
Protagonist Therapeutics
Last Price:
31.43
Seasonality Move:
16.08%
7 Day Trial
ALL ACCESS PASS
$
7
Protagonist Therapeutics Price Quote
$31.43
-0.04 (6.15%)
(Updated: May 16, 2024 at 6:18 AM ET)
Protagonist Therapeutics Key Stats
Buy
75
Protagonist Therapeutics (PTGX)
is a Buy
Day range:
$29.93 - $32.25
52-week range:
$13.72 - $33.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.29%
Volume:
676.1K
Avg. volume:
522.8K
1-year change:
21.18%
Market cap:
$1.8B
Revenue:
$60M
EPS:
$2.44
How Much Does Protagonist Therapeutics Make?
Data Unavailable
Is Protagonist Therapeutics Growing As A Company?
Data Unavailable
Protagonist Therapeutics Stock Price Performance
-
Did Protagonist Therapeutics Stock Go Up Last Month?
Protagonist Therapeutics share price went up by 18.4% last month -
Did PTGX's Share Price Rise Over The Last Year?
PTGX share price rose by 21.18% over the past 1 year
What Is Protagonist Therapeutics 52-Week High & Low?
-
What Is Protagonist Therapeutics’s 52-Week High Share Price?
Protagonist Therapeutics has traded as high as $33.34 over the past 52 weeks -
What Is Protagonist Therapeutics’s 52-Week Low Share Price?
Protagonist Therapeutics has traded as low as $13.72 over the past 52 weeks
Protagonist Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Protagonist Therapeutics?
-
How Much Debt Does Protagonist Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Protagonist Therapeutics Have?
Cash and short term investments quarterly total is $322.6M -
What Is Protagonist Therapeutics’s Book Value Per Share?
Book value per share is 9.56
Is Protagonist Therapeutics Cash Flow Positive?
-
What Is PTGX Cash Flow From Operations?
Cash flow from operations (TTM) is -$63.3M -
What Is Protagonist Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $151.2M -
What Is Protagonist Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$43M
Protagonist Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
PTGX return on invested capital is 47.41% -
What Is Protagonist Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 43.17% -
What Is PTGX Return On Equity?
ROE is a measure of profitability and is 47.41%
Protagonist Therapeutics Earnings Date & Stock Price
-
What Is Protagonist Therapeutics's Stock Price Today?
A single share of PTGX can be purchased today for 31.47 -
What Is Protagonist Therapeutics’s Stock Symbol?
Protagonist Therapeutics trades on the nasdaq under the ticker symbol: PTGX -
When Is Protagonist Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Protagonist Therapeutics is scheduled on August 2, 2024 -
When Is PTGX's next ex-dividend date?
Protagonist Therapeutics's next ex-dividend date is May 16, 2024 -
How To Buy Protagonist Therapeutics Stock?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Protagonist Therapeutics Competitors
-
Who Are Protagonist Therapeutics's Competitors?
Below is a list of companies who compete with Protagonist Therapeutics or are related in some way:
Protagonist Therapeutics Dividend Yield
Data Unavailable
Protagonist Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 103.79% |
| Revenue: | 0% | 112.46% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 43.50 |
| Upside from Last Price: | 38.23% |